Eiger Biopharmaceuticals Stock Last Dividend Paid
EIGRDelisted Stock | USD 0.74 0.03 3.90% |
Eiger Biopharmaceuticals fundamentals help investors to digest information that contributes to Eiger Biopharmaceutica's financial success or failures. It also enables traders to predict the movement of Eiger Stock. The fundamental analysis module provides a way to measure Eiger Biopharmaceutica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eiger Biopharmaceutica stock.
Eiger |
Eiger Biopharmaceuticals Company Last Dividend Paid Analysis
Eiger Biopharmaceutica's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
CompetitionBased on the recorded statements, Eiger Biopharmaceuticals has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
All Next | Launch Module |
Eiger Fundamentals
Return On Equity | -2.26 | |||
Return On Asset | -0.52 | |||
Operating Margin | (5.28) % | |||
Current Valuation | 3.88 M | |||
Shares Outstanding | 1.48 M | |||
Shares Owned By Insiders | 11.79 % | |||
Shares Owned By Institutions | 43.86 % | |||
Number Of Shares Shorted | 29.81 K | |||
Price To Earning | (2.04) X | |||
Price To Book | 0.87 X | |||
Price To Sales | 0.17 X | |||
Revenue | 15.77 M | |||
Gross Profit | 11.65 M | |||
EBITDA | (68.74 M) | |||
Net Income | (74.96 M) | |||
Cash And Equivalents | 141.79 M | |||
Cash Per Share | 3.22 X | |||
Total Debt | 41.2 M | |||
Debt To Equity | 0.38 % | |||
Current Ratio | 7.22 X | |||
Book Value Per Share | (1.08) X | |||
Cash Flow From Operations | (74.55 M) | |||
Short Ratio | 3.72 X | |||
Earnings Per Share | (58.50) X | |||
Target Price | 30.0 | |||
Number Of Employees | 56 | |||
Beta | 1.85 | |||
Market Capitalization | 2.55 M | |||
Total Asset | 38.83 M | |||
Retained Earnings | (512.16 M) | |||
Working Capital | (15.45 M) | |||
Current Asset | 57.21 M | |||
Current Liabilities | 5.35 M | |||
Net Asset | 38.83 M |
About Eiger Biopharmaceutica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eiger Biopharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eiger Biopharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eiger Biopharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Eiger Biopharmaceutica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eiger Biopharmaceutica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eiger Biopharmaceutica will appreciate offsetting losses from the drop in the long position's value.Moving together with Eiger Stock
0.83 | PPERY | Bank Mandiri Persero | PairCorr |
0.65 | PPERF | Bank Mandiri Persero | PairCorr |
0.61 | BKRKF | PT Bank Rakyat | PairCorr |
Moving against Eiger Stock
0.79 | BAC | Bank of America Aggressive Push | PairCorr |
0.75 | CSCO | Cisco Systems Aggressive Push | PairCorr |
0.66 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
0.65 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.65 | WMT | Walmart Aggressive Push | PairCorr |
The ability to find closely correlated positions to Eiger Biopharmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eiger Biopharmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eiger Biopharmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eiger Biopharmaceuticals to buy it.
The correlation of Eiger Biopharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eiger Biopharmaceutica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eiger Biopharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eiger Biopharmaceutica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Eiger Stock
If you are still planning to invest in Eiger Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eiger Biopharmaceutica's history and understand the potential risks before investing.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |